FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking concerns over patient access to the compounded diabetes and obesity treatment. read more
FDA Sparks Controversy With Sudden Removal Of Eli Lilly’s Weight Loss Drug From Shortage List